Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1976 Dec;26(3):647–649.

Adenosine deaminase activity in thymus and other human tissues.

A Adams, R A Harkness
PMCID: PMC1540957  PMID: 1009688

Abstract

Adenosine deaminase activity (ADA) has been estimated in human tissues. Levels in the thymus during childhood were very much higher than in any of the other 6 tissues studied. Intermediate activities were obtained from spleen and lymph nodes and also skin. Cerebral cortex, liver and kidney had relatively low levels. ADA activity in lymphocytes from peripheral blood was significantly increased after antigenic stimulation by TAB immunization. The available evidence appears to be consistent with T-lymphocyte growth and development in the thymus being dependant on ADA.

Full text

PDF
647

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLOCK W. D., JOHNSON D. V. Studies of the enzymes of purine metabolism in skin. II. Nucleoside deaminases of rat skin. J Invest Dermatol. 1954 Dec;23(6):471–478. [PubMed] [Google Scholar]
  2. BRADY T. G., O'DONOVAN C. I. A STUDY OF THE TISSUE DISTRIBUTION OF ADENOSINE DEAMINASE IN SIX MAMMAL SPECIES. Comp Biochem Physiol. 1965 Jan;14:101–120. doi: 10.1016/0010-406x(65)90011-3. [DOI] [PubMed] [Google Scholar]
  3. Carson D. A., Seegmiller J. E. Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis. J Clin Invest. 1976 Feb;57(2):274–282. doi: 10.1172/JCI108278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Giblett E. R., Ammann A. J., Wara D. W., Sandman R., Diamond L. K. Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity. Lancet. 1975 May 3;1(7914):1010–1013. doi: 10.1016/s0140-6736(75)91950-9. [DOI] [PubMed] [Google Scholar]
  5. HALL J. G. Adenosine deaminase activity in lymphoid cells during antibody production. Aust J Exp Biol Med Sci. 1963 Feb;41:93–97. doi: 10.1038/icb.1963.8. [DOI] [PubMed] [Google Scholar]
  6. Hirschhorn R. Conversion of human erythrocyte-adenosine deaminase activity to different tissue-specific isozymes. Evidence for a common catalytic unit. J Clin Invest. 1975 Mar;55(3):661–667. doi: 10.1172/JCI107974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hovi T., Smyth J. F., Allison A. C., Williams S. C. Role of adenosine deaminase in lymphocyte proliferation. Clin Exp Immunol. 1976 Mar;23(3):395–403. [PMC free article] [PubMed] [Google Scholar]
  8. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  9. McGuire T. C., Pollara B., Moore J. J., Poppie M. J. Evaluation of adenosine deaminase and other purine salvage pathway enzymes in horses with combined immunodeficiency. Infect Immun. 1976 Mar;13(3):995–997. doi: 10.1128/iai.13.3.995-997.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rothman I. K., Silber R., Klein K. M., Becker F. F. Nucleoside deaminase and adenosine deaminase activities in regenerating mouse liver. Biochim Biophys Acta. 1971 Jan 28;228(2):307–312. doi: 10.1016/0005-2787(71)90038-4. [DOI] [PubMed] [Google Scholar]
  11. Tung R., Silber R., Quagliata F., Conklyn M., Gottesman J., Hirschhorn R. Adenosine deaminase activity in chronic lymphocytic leukemia. Relationship to B- and T-cell subpopulations. J Clin Invest. 1976 Mar;57(3):756–761. doi: 10.1172/JCI108334. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES